8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) December 10, 2003

ST. JUDE MEDICAL, INC.
(Exact name of registrant as specified in its chapter)

Minnesota	0-8672	41-1276891
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)
One Lillehei Plaza, St. Paul, MN		55117
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code (651) 483-2000

Not applicable
(Former name or former address, if changed since last report)

Item 9.    Regulation FD Disclosure

On December 10, 2003, the Registrant issued a press release concerning the retirement in May 2004 of CEO and Chairman Terry Shepherd and plans for Daniel Starks to succeed him, a copy of which is furnished herewith as Exhibit 1.

SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ST. JUDE MEDICAL, INC.
Date: December 10, 2003	By:  /s/  Kevin T. O'Malley Kevin T. O'Malley Vice President and General Counsel

EXHIBIT INDEX

Exhibit	Description of Exhibit
1	Press Release, dated December 10, 2003

EX-99.1

Exhibit 1
- ---------


        ST. JUDE MEDICAL CHAIRMAN AND CEO TERRY SHEPHERD TO RETIRE IN MAY
             2004; PRESIDENT AND COO DAN STARKS TO SUCCEED SHEPHERD

ST. PAUL, MN, December 10, 2003 -- St. Jude Medical, Inc. (NYSE: STJ) announced
today that Chairman and Chief Executive Officer Terry L. Shepherd has decided to
retire effective with the Company's annual meeting in May 2004. Mr. Shepherd
became Chief Executive Officer of St. Jude Medical in May 1999 and was elected
Chairman of the Board in May 2002. The Board of Directors has elected President
and Chief Operating Officer Daniel J. Starks to succeed Mr. Shepherd as Chief
Executive Officer and Chairman of the Board of Directors, effective upon Mr.
Shepherd's retirement. Mr. Shepherd will also retire from the St. Jude Medical
Board of Directors in May 2004.

Daniel J. Starks, 49, is a 19 year veteran of St. Jude Medical, including his
tenure with the Daig Corporation it acquired in 1996. Mr. Starks became
President and Chief Operating Officer of St. Jude Medical in February 2001. Mr.
Starks previously served as CEO and President of its Cardiac Rhythm Management
business, CEO and President of its Daig business, and as a Director and
President of Daig Corporation. Mr. Starks has been a member of the St. Jude
Medical Board of Directors since the Company acquired Daig Corporation in 1996.
Mr. Starks graduated from the University of Minnesota Law School magna cum laude
in 1979 and began his career practicing law in Minnesota. Terry L. Shepherd, 50,
joined St. Jude Medical as President of its Heart Valve business in October
1994. He has worked in the medical technology industry for 22 years. Mr.
Shepherd underwent successful open heart surgery in July 2003.

"Today's announcement reflects a very natural leadership transition process and
the great confidence that I and the Board of Directors have in Dan Starks and
the next generation of leadership at St. Jude Medical," said Terry L. Shepherd.
"When Dan was elevated to the position of President and Chief Operating Officer
in early 2001, it was with the clear intention to prepare for this transition.
The Company is now in superb shape, the next growth opportunities for St. Jude
Medical are now unfolding on schedule and the leadership team is stronger than
it ever has been and deserves the opportunity to step forward. Dan and I have
worked together effectively as partners leading St. Jude Medical over the past
several years and I expect this transition to be absolutely seamless."

Dan Starks said, "All of St. Jude Medical salutes Terry Shepherd for his
leadership and example as Chairman and CEO, colleague, and technologist
completely focused at all times on doing what is best for patients, medical care
providers, our shareholders and our employees on a global basis. We will benefit
from Terry's legacy for years to come. Our market opportunity, technology, and
employees all are positioned for sustained growth and success as we expand the
ways we can help patients suffering from atrial fibrillation, other cardiac
rhythm disorders, heart failure, coronary artery disease and heart valve
defects. I am privileged to have worked so closely with Terry. I look forward to
carrying on our disease management programs together with all of the members of
the St. Jude Medical team."

St. Jude Medical, Inc. (www.sjm.com) is dedicated to the design, manufacture and
distribution of innovative medical devices of the highest quality, offering
physicians, patients and payers unmatched clinical performance and demonstrated
economic value.